The study highlights poor outcomes for leukaemia patients with a history of myelodysplastic syndrome treatment and related ...

未来研究中，研究人员希望能通过更为深入地研究来阐明是否这种量身定做的免疫细胞也能在人类机体中发挥作用。综上，本文研究结果表明，缺失NKG2A的CAR-NK细胞或有望能绕过患者机体急性髓性白血病的免疫抑制作用。（ 生物谷 Bioon.com） ...

近年来，山东省脐血库与上海交通大学医学院附属瑞金医院携手密切合作，在脐带血医学研究领域取得了显著进展。双方共同开展了多项前沿探索，涵盖了 造血干细胞的重编程技术、脐带血单个核细胞培养DC以及脐带血单个核细胞治疗肝衰模型等 ...

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today ...

Biotherapeutics company PureTech Health plc (PRTC) announced Thursday that the U.S. Food and Drug Administration (FDA) has granted ...

SMART-101 is under clinical development by Smart Immune and currently in Phase II for Refractory Acute Myeloid Leukemia.

通过单细胞RNA测序（scRNA-seq）技术， 研究人员发现脐带血具有显著的抗肿瘤和抗衰老特性。 这些特性表现为免疫反应的激活以及端粒的合成和维持能力的增强。 端粒长度通常被认为与寿命存在关联， 随着年龄的增加，人体细胞的端粒逐渐缩短，导致细胞功能衰退，组织和器官功能下降，从而出现各种衰老相关的症状和疾病，而端粒的合成和维持能力的增强意味着在”抗衰老”上拥有了新的希望与突破。

A young man has been diagnosed with acute stage 3 leukemia and urgently needs help to survive. He has appealed to the general ...

A new study evaluating the quadratic phenotypic optimization platform shows it can accurately predict personalized drug ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Emergency and Critical Care Medicine 2024年第4期创伤专题正式上线, 本期由1篇Perspective/Viewpoint，3篇Original article，2篇Review，1篇Communication ...